Zacks Research Decreases Earnings Estimates for Integer

Integer Holdings Co. (NYSE:ITGR) – Stock analysts at Zacks Research dropped their FY2025 earnings estimates for shares of Integer in a note issued to investors on Tuesday, October 22nd. Zacks Research analyst D. Dey now anticipates that the medical equipment provider will post earnings per share of $6.03 for the year, down from their previous forecast of $6.04. The consensus estimate for Integer’s current full-year earnings is $5.30 per share. Zacks Research also issued estimates for Integer’s Q1 2026 earnings at $1.64 EPS, Q3 2026 earnings at $1.66 EPS and FY2026 earnings at $6.68 EPS.

Integer (NYSE:ITGR) last posted its earnings results on Thursday, October 24th. The medical equipment provider reported $1.43 EPS for the quarter, topping analysts’ consensus estimates of $1.36 by $0.07. The business had revenue of $431.42 million for the quarter, compared to analysts’ expectations of $440.59 million. Integer had a return on equity of 11.48% and a net margin of 6.31%. The business’s revenue was up 8.7% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $1.27 earnings per share.

A number of other research firms have also commented on ITGR. Bank of America lifted their price objective on shares of Integer from $135.00 to $145.00 and gave the company a “buy” rating in a research note on Tuesday, October 1st. Truist Financial upped their price objective on Integer from $145.00 to $150.00 and gave the company a “buy” rating in a research note on Monday, October 14th. Citigroup increased their price objective on Integer from $124.00 to $130.00 and gave the stock a “neutral” rating in a research report on Tuesday, October 1st. Oppenheimer assumed coverage on Integer in a research note on Tuesday, July 16th. They set an “outperform” rating and a $135.00 price target for the company. Finally, Benchmark lifted their price objective on shares of Integer from $130.00 to $140.00 and gave the company a “buy” rating in a research report on Monday. One analyst has rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, the stock has an average rating of “Moderate Buy” and an average price target of $140.14.

Integer Price Performance

Shares of NYSE ITGR opened at $126.84 on Wednesday. The stock has a 50 day moving average of $127.37 and a two-hundred day moving average of $120.86. The stock has a market cap of $4.25 billion, a P/E ratio of 43.86, a P/E/G ratio of 1.86 and a beta of 1.08. Integer has a twelve month low of $69.40 and a twelve month high of $133.53. The company has a current ratio of 3.29, a quick ratio of 1.96 and a debt-to-equity ratio of 0.73.

Insider Buying and Selling

In related news, Director Jean M. Hobby sold 11,960 shares of the firm’s stock in a transaction dated Wednesday, July 31st. The shares were sold at an average price of $119.66, for a total value of $1,431,133.60. Following the completion of the sale, the director now owns 2,280 shares in the company, valued at $272,824.80. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 2.00% of the stock is currently owned by corporate insiders.

Hedge Funds Weigh In On Integer

Hedge funds have recently added to or reduced their stakes in the business. GSA Capital Partners LLP purchased a new position in Integer during the first quarter worth $786,000. Blue Trust Inc. grew its position in Integer by 460.4% during the second quarter. Blue Trust Inc. now owns 5,643 shares of the medical equipment provider’s stock valued at $658,000 after acquiring an additional 4,636 shares during the period. UniSuper Management Pty Ltd purchased a new stake in shares of Integer during the 1st quarter worth about $976,000. Moloney Securities Asset Management LLC acquired a new stake in shares of Integer in the first quarter worth $927,000. Finally, Earnest Partners LLC lifted its holdings in shares of Integer by 3.2% during the 2nd quarter. Earnest Partners LLC now owns 1,208,319 shares of the medical equipment provider’s stock valued at $139,911,000 after acquiring an additional 37,340 shares in the last quarter. 99.29% of the stock is currently owned by hedge funds and other institutional investors.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.